NDC 10135-738
Rifabutin
Rifabutin
Rifabutin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Marlex Pharmaceuticals, Inc.. The primary component is Rifabutin.
| Product ID | 10135-738_df7d4103-42e5-4e4f-e053-2a95a90a8ce8 |
| NDC | 10135-738 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Rifabutin |
| Generic Name | Rifabutin |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-05-01 |
| Marketing Category | ANDA / |
| Application Number | ANDA215041 |
| Labeler Name | Marlex Pharmaceuticals, Inc. |
| Substance Name | RIFABUTIN |
| Active Ingredient Strength | 150 mg/1 |
| Pharm Classes | Rifamycin Antimycobacterial [EPC], Rifamycins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |